Cancer and Leukemia Group B
Chicago, Illinois 60606
0 studies enrolling now · 40 studies all time
What they study most
Acinar Cell Adenocarcinoma of the Pancreas, Acute Undifferentiated Leukemia, Adenocarcinoma of the Colon, Adenocarcinoma of the Lung, Adenocarcinoma of the Pancreas, Adenocarcinoma of the Prostate, Adenocarcinoma of the Rectum, Adenosquamous Cell Lung Cancer, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7)
Studies at this site
- Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia — Completed
- Edrecolomab in Treating Patients With Stage II Colon Cancer — Completed
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia — Completed
- Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia — Completed
- Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma — Completed
- Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer — Completed
- SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed
- Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer — Completed
- Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia — Completed
- Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy — Completed
- Combination Chemotherapy in Treating Patients With Stage III Colon Cancer — Completed
- Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer — Completed
- Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer — Completed
- Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer — Completed
- Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia — Completed
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer — Completed
- Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. — Completed
- Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed
- Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma — Completed
- Tipifarnib in Treating Patients With Metastatic Malignant Melanoma — Completed
- Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia — Completed
- Arsenic Trioxide in Treating Patients With Urothelial Cancer — Completed
- Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia — Completed
- Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine — Completed
- Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic — Completed
- Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia — Completed
- Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium — Stopped early
- Gefitinib in Treating Patients With Malignant Mesothelioma — Completed
- Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma — Completed
- Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia — Completed
- Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer — Stopped early
- Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer — Completed
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction — Completed
- Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma — Completed
- 506U78 in Treating Patients With Lymphoma — Completed
- Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 — Completed
- Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer — Stopped early
- Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum — Completed
- Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer — Completed
- Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma — Stopped early